World's Best Scientists 2026 revealed!
Award Badge
Medicine
France
2023

D-Index & Metrics

Medicine

D-Index
139
Citations
61271
World Ranking
1776
National Ranking
46

Philippe Ravaud publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Philippe Ravaud sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 681 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Philippe Ravaud D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Philippe Ravaud sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 139 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in France Leader Award

Overview

Philippe Ravaud is affiliated with Université Paris Cité in France and has a substantial publication record primarily in the field of Medicine. Their research covers a variety of subfields including Public Health, Environmental and Occupational Health, Statistics, Probability and Uncertainty, Infectious Diseases, Economics and Econometrics, and Neurology.

Their main research topics include meta-analysis and systematic reviews, health systems, economic evaluations, quality of life, long-term effects of COVID-19, COVID-19 clinical research studies, ethics in clinical research, SARS-CoV-2 and COVID-19 research, and the Delphi technique in research.

Notable recent papers authored or co-authored by Philippe Ravaud include:

  • Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia (2020), published in JAMA Internal Medicine
  • Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data (2020), published in BMJ
  • Efficacy and safety of COVID-19 vaccines (2022), published in Cochrane Database of Systematic Reviews
  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial (2021), published in The Lancet Respiratory Medicine
  • Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort (2022), published in Nature Communications

Frequent co-authors collaborating with Philippe Ravaud include:

  • Isabelle Boutron
  • Asbjørn Hróbjartsson
  • Joerg J Meerpohl
  • David Tovey
  • Anna Chaimani

The scientist has published extensively in recognized venues, with the most frequent being:

  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of Clinical Epidemiology
  • BMJ
  • OPAL (Open@LaTrobe) (La Trobe University)
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • A prospective survey of patients with valvular heart disease in Europe : The Euro Heart Survey on Valvular Heart Disease.

    Bernard Iung;Gabriel Baron;Eric G. Butchart;François Delahaye

  • Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.

    Isabelle Boutron;David Moher;Douglas G Altman;Kenneth F Schulz

  • Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery?

    Bernard Iung;Agnès Cachier;Gabriel Baron;David Messika-Zeitoun

  • Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement

    F Tubach;P Ravaud;G Baron;B Falissard

  • CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts

    Isabelle Boutron;Douglas G Altman;David Moher;Kenneth F Schulz

  • Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

    Loïc Guillevin;Christian Pagnoux;Alexandre Karras;Chahera Khouatra

  • Artificial intelligence in health care: value for whom?

    Jean-David Zeitoun;Philippe Ravaud;Philippe Ravaud

  • What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?

    Mariana Mirabel;Bernard Iung;Gabriel Baron;David Messika-Zeitoun

  • EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome

    Raphaele Seror;Philippe Ravaud;Simon J. Bowman;Gabriel Baron

  • Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry

    Florence Tubach;Dominique Salmon;Philippe Ravaud;Yannick Allanore

  • Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.

    Isabelle Boutron;Susan Dutton;Philippe Ravaud;Douglas G. Altman

  • Comparison of registered and published primary outcomes in randomized controlled trials.

    Sylvain Mathieu;Isabelle Boutron;David Moher;Douglas G. Altman

  • High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.

    Jean-Paul Fermand;Philippe Ravaud;Sylvie Chevret;Marine Divine

  • Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.

    Olivier Hermine;Olivier Hermine;Xavier Mariette;Pierre-Louis Tharaux;Matthieu Resche-Rigon

  • Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state

    F Tubach;P Ravaud;G Baron;B Falissard

  • Infective endocarditis in Europe: lessons from the Euro heart survey

    P Tornos;B Iung;G Permanyer-Miralda;G Baron

  • Methods and Processes of the CONSORT Group: Example of an Extension for Trials Assessing Nonpharmacologic Treatments

    Isabelle Boutron;David Moher;Douglas G Altman;Kenneth F Schulz

  • High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

    Jean-Paul Fermand;Sandrine Katsahian;Marine Divine;Veronique Leblond

  • Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

    Xavier Mariette;Philippe Ravaud;Serge Steinfeld;Gabriel Baron

  • Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration

    I Boutron;D Moher;D G Altman;K F Schulz

Frequent Co-Authors

Isabelle Boutron
Isabelle Boutron Université Paris Cité
Maxime Dougados
Maxime Dougados Hôpital Cochin
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Raphaël Porcher
Raphaël Porcher Université Paris Cité
Jean Sibilia
Jean Sibilia University of Strasbourg
Xavier Puéchal
Xavier Puéchal Université Paris Cité
Bernard Combe
Bernard Combe University of Montpellier
Bruno Fautrel
Bruno Fautrel Université Paris Cité
Douglas G. Altman
Douglas G. Altman University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are several online degree options and career pathways worth exploring. For nursing professionals, pursuing an rn to bsn online can be a flexible and affordable route to advancing your qualifications while balancing work and study.

If you hold a non-nursing bachelor’s degree but want to enter the nursing field, direct entry msn programs for non-nursing majors offer a fast-tracked way into advanced nursing roles. There are also options for career changers, as online bsn programs for non nurses can provide a more accessible pathway to starting your nursing journey.

For those interested in the administrative side of healthcare, medical billing and coding schools online with financial aid can help you enter an in-demand career that supports the medical industry behind the scenes.

Each of these online programs is designed to be flexible, helping you balance personal commitments with advancing your education and career in the fast-growing healthcare sector.

Best Scientists Citing Philippe Ravaud

Trending Scientists

Recently Published Articles